Company signals · MedTech
Sonova
1 signal in the current window, with MitchelLake's leadership read on each.
Market context: This lands while the Talent Market Index reads 98.6 (Neutral) — down 1.4 versus the prior month — and EMEA signal share is steady (-1.1pts).
Sonova: 1 signal in the last 90 days — in line with the MedTech median of 1 across 18 tracked companies; 0.1% of MitchelLake's EMEA signal flow.
Signals at Sonova
More signals across MedTech
Product Launch · EMEA
Abbott →Abbott launched CE-marked dual glucose-ketone Libre Duo sensors in Europe through expanded partnership with MiniMed, representing first-of-its-kind dual-analyte diabetes technology
Product Launch · EMEA
ZEISS Medical Technology →ZEISS successfully completed early clinical implantations of AT LUCIA toric 721P intraocular lens across six European countries. Product is CE marked and expected to launch commercially in select European markets later in 2026.
Product Launch · EMEA
Beckman Coulter Diagnostics →Beckman Coulter Diagnostics earned CE Mark for new Access MeMed BV Assay that delivers bacterial vs viral infection results in ~20 minutes, with potential €80M cost savings across European health systems
Partnership · EMEA
Cepheid →Cepheid launched landmark 30-month study with the Fleming Initiative at London NHS Trusts to evaluate rapid CPE screening for drug-resistant infections
Ma Activity · EMEA
Medtronic →Medtronic completed its acquisition of Scientia Vascular, integrating neurovascular access and therapeutic portfolios.
Partnership · EMEA
Sectra →Sectra signed contract to deliver enterprise imaging cloud service to six NHS Trusts in London
Intelligence powered by Autonodal ↗